Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor

Progress in Neurobiology

Volumn 60, Issue 6, 2000, Pages 513-530

  Stefano, George B ^a   Goumon, Yannick ^a   Bilfinger, Thomas V ^a   Welters, Ingeborg D ^a   Cadet, Patrick ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Anandamide; Endothelial mu opiate receptor; Estrogen; Morphine; Nitric oxide; Opiate receptor

Indexed keywords

ANANDAMIDE; ESTRADIOL; INTERLEUKIN 10; MORPHINE; MU OPIATE RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIATE RECEPTOR;

BINDING AFFINITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ESTRADIOL BLOOD LEVEL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; BASE SEQUENCE; CARDIOVASCULAR PHYSIOLOGY; ENDOTHELIUM; HUMANS; IMMUNE SYSTEM; MOLECULAR SEQUENCE DATA; NERVOUS SYSTEM PHYSIOLOGY; NITRIC OXIDE; RECEPTORS, OPIOID, MU;

EID: 0033963935     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00038-6     Document Type: Review

References (188)

1. Al-Afaleq A.I., Homeida A.M. Effects of low doses of oestradiol, testosterone and dihydrotestosterone on the immune response of broiler chicks. Immunopharmacology & Immunotoxicology. 20:1998;315-327.
2. Assreuy J., Cunha F.Q., Liew F.Y., Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108:1993;833-837.
3. Ayata C., Ayata G., Hara H., Matthews R.T., Beal M.F., Ferrante R.J., Endres M., Kim A., Christie R.H., Waeber C., Huang P.L., Hyman B.T., Moskowitz M.A. Mechanisms of reduced striatal NMDA excitotoxicity in type 1 nitric oxide synthase knock-out mice. J. Neurosci. 17:1997;6908-6917.
4. Bath P.M.W., Hasall D.G., Gladwin A.M., Palmer R.M., Martin J.F. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. 11:1991;254-260.
5. Bayon Y., Alonso A., Sanchez Crespo M. Immunoglobulin-E/dinitrophenyl complexes induce nitric oxide synthesis is rat peritoneal macrophages by a mechanism involving CD23 and NF-kappa B activation. Biochem. Biophys. Res. Commun. 242:1998;570-574.
6. Ben-Hur H., Mor G., Insler V., Blickstein I., Amir-Zaltsman Y., Sharp A., Globerson A., Kohen F. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. American Journal of Reproductive Immunology. 34:1995;363-369.
7. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 11:1993;767-804.
8. Bhargava H.N. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase. Gen. Pharmacol. 26:1995;1049-1053.
9. Bilfinger T.V., Stefano G.B. Cellular aspects of cardiopulmonary bypass surgery. Int. J. Cardiol. 53S:1996;R7.
10. Bilfinger, T.V., Stefano, G.B., 1999. Human aortocoronary grafts and nitric oxide release: Relationship to pulsatile pressure. Annals of Thoracic Surgery, in Press.
11. Bilfinger T.V., Fricchione G.L., Stefano G.B. Neuroimmune implications of cardiopulmonary bypass. Adv. Neuroimmunol. 3:1993;277-288.
12. Bilfinger T.V., Kushnerik V., Bundz S., Liu Y., Stefano G.B. Evidence for morphine downregulating immunocytes during cardiopulmonary bypass in a porcine model. Int. J. Cardiol. 53:1996;S39-S46.
13. Bilfinger T.V., Hartman A., Liu Y., Magazine H.I., Stefano G.B. Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann. Thorac. Surg. 63:1997;1063-1069.
14. Bilfinger T.V., Salzet M., Fimiani C., Deutsch D.G., Stefano G.B. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues. Int. J. Cardiol. 64:1998;S15-S22.
15. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J. Immunol. 157:1996;1630-1637.
16. Bodnar A., Pasternak G.W. Aging and analgesic mechanisms. Makman M.H., Stefano G.B. Neuroregulatory Mechanisms in Aging. 1993;137-158 Pergamon Press, Oxford.
17. Bone R.C. The pathogenesis of sepsis. Ann. Int. Med. 115:1991;457-469.
18. Boulanger C., Luscher T.F. Release of endothelin from the porcine aorta-inhibition by endothelium-derived nitric acid. J. Clin. Invest. 85:1990;587-590.
19. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci, USA. 87:1990;682-685.
20. Burnette-Curley D., Cabral G.A. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta-9-tetrahydrocannabinol. Proc. Soc. Exp. Biol. Med. 210:1995;64-76.
21. Cabral G.A., Fischer-Stenger K. Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. Life Sci. 54:1994;1831-1844.
22. Calignano A., Persico P., Mancuso F., Sorrentino L. Endogenous nitric oxide modulates norphine-induced changes in locomotion and food intake in mice. Eur. J. Pharmacol. 321:1993;415.
23. Catalano M., Carzaniga G., Perilli E., Jun T., Scandale G., Andreoni S., Carotta M. Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus. Vascular Medicine. 2:1997;302-305.
24. Chen C.C., Rosenbloom C.L., Anderson D.C., Manning A.M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 155:1995;3538-3545.
25. Clancy R.M., Leszczynska-Piziak J., Abramson S.B. Nitric Oxide stimulates the ADP-ribosylation of actin in human neutrophils. Biochem. Biophys. Res. Commun. 191:1993;847-852.
26. Colasanti M., Persichini T., Menegazzi M., Mariotto S., Giordano E., Caldarera C.M., Sogos V., Lauro G.M., Suzuki H. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 270:1995;26731-26733.
27. Cooke J.P., Dzau V.J. Nitric oxide synthase: role in the genesis of vascular disease. Ann. Rev. Med. 48:1997;489-509.
28. Dambisya Y.M., Lee T.L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br. J. Pharmacol. 117:1996;914-918.
29. Dawson V.L., Dawson T.M. Physiological and toxicological actions of nitric oxide in the central nervous system. Adv. Pharmacol. 34:1995;323-342.
30. Dawson T.M., Dawson V.L. Nitric oxide synthase: role as a transmitter/mediator in the brain and endocrine system. Ann. Rev. of Med. 47:1996;219-227.
31. Dawson V.L., Dawson T.M. Nitric oxide neurotoxicity. J. Chem. Neuroanatomy. 10:1996;179-190.
32. DeCaterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone M.A. Jr, Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:1995;60-81.
33. Dembinska-Kiec A., Zmuda A., Wenhrynowicz O., Stachura J., Peskar B.A., Gryglewski R.J. Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide. Intl. J. Tiss. Reactions. 15:1993;55-64.
34. Deutsch D.G., Goligorsky M.S., Schmid P.C., Krebsbach R.J., Schmid H.H.O., Das S.K., Dey S.K., Stefano G.B., Arreaza R., Thorup C., Moore L. Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100:1997;1538-1546.
35. Dobrenis K., Makman M.H., Stefano G.B. Occurrence of the opiate alkaloid-selective m3 receptor in mammalian microglia, astrocytes and kupffer cells. Brain Res. 686:1995;239-248.
36. Donahoe R.M., Vlahov D. Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J. Neuroimmunol. 83:1998;77-87.
37. Duarte I.D., Ferreira S.H. The molecular mechanism of central analgesia iduced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 221:1992;171.
38. Faraci F.M., Heistad D.D. Regulation of the cerebral circulation: role of endothelium and potassium channels. Phys. Rev. 78:1998;53-97.
39. Fecho K., Maslonek K.A., Coussons-Read M.E., Dykstra L.A., Lysle D.T. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152:1994;5845.
40. Ferreira S.H., Duarte I.D., Lorenzetti B.B. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 201:1991;121.
41. Fimiani C., Mattocks D.W., Cavani F., Salzet M., Deutsch D.G., Pryor S.C., Bilfinger T.V., Stefano G.B. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell. Signaling. 11:1999;189-193.
42. Fimiani C., Liberty T., Aquirre A.J., Amin I., Ali N., Stefano G.B. Opiate, cannabinoid, and eicosanoid signaling converges on common intracellular pathways: nitric oxide coupling. Prostaglandins. 57:1999;23-34.
43. Fricchione G.L., Stefano G.B. The stress response and autoimmunoregulation. Adv. Neuroimmunol. 4:1994;13-28.
44. Friedman M., Cepero M.L., Klein T., Friedman H. Suppressive effect of delta-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc. Soc. Exp. Biol. Med. 182:1986;225-228.
45. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intracellular messenger in the brain. Nature. 336:1988;385-388.
46. Garzetti G.G., Ciavattini A., Provinciali M., Amati M., Muzzioli M., Governa. Decrease in peripheral blood polymorphonuclear leukocyte chemotactic index in endometriosis: role of prostaglandin E2 release. Obstetrics & Gynecology. 91:1998;25-29.
47. Griscavage J.M., Rogers N.E., Sherman M.P., Ignarro L.J. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151:1993;6329-6337.
48. Gyires K. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur. J. Pharmacol. 255:1994;33.
49. Hanbauer I., Grilli M. Molecular mechanisms involved in transport and release of dopamine in primary cultures of mesencephalic neurons. Neurochem. Int. 20:1992;101S-105S.
50. Hanbauer I., Wink D., Osawa Y., Edelman G.M., Gally J.A. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport. 3:1992;409-412.
51. Ho B.T., Huo Y.Y., Lu J.G., Tansey L.W., Levin V.A. Opioid-dopaminergic mechanisms in the potentiation of d-amphetamine discrimination by interferon-alpha. Pharmacol. Biochem. Behav. 42:1992;57-60.
52. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20:1997;298-303.
53. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient of neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
54. Huszka M., Kaplar M., Rejto L., Tornai I., Palatka K., Laszlo P., Udvardy M. The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. Thrombosis Research. 86:1997;173-180.
55. Ito I., Hayashi T., Yamada K., Kuzuya M., Naito M., Iguchi A. Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system. Life Sciences. 56:1995;2247-2253.
56. Iuvone T., D'Acquisto F., Van Osselaer N., Di Rosa M., Carnuccio R., Herman A.G. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappa B. Brit. J. Pharmacol. 123:1998;1325-1330.
57. Jean A.P., Maloteaux J.M., Laduron P.M. IL-1 beta-like Freund's adjuvant enhances axonal transport of opiate receptors in sensory neurons. Neurosci. Lett. 177:1994;75-78.
58. Joseph D.B., Bidlack J.M. The k-opioid receptor expressed on the mouse lymphoma cell line R1.1 contains a sulfhydryl group at the active site. Eur. J. Pharmacol. 267:1994;1-6.
59. Jun C.D., Han M.K., Kim U.H., Chung H.T. Nitric oxide stimulates the ADP-ribosylation of actin in murine macrophages: association with the inhibition of pseudopodia formation, phagocytic activity, and adherence on a laminal substratum. Cell. Immunol. 174:1996;25-31.
60. Kieffer B.L., Befort K., Gaveriaux-Ruff C.E., Hirth C.G. The d-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA. 89:1992;12048-12052.
61. Kimura T., Ota K., Matsui K., Iitake K., Shoji M., Inoue M., Yoshinaga K., Share L. The presence of methionine-enkephalin in plasma and urine in normal human subjects and various patients. Endocrinol. Jpn. 32:1985;514-517.
62. Kinoshita H., Tsutsui M., Milstien S., Katusic Z.S. Tetrahydrobiopterin, nitric oxide and regulation of cerebral arterial tone. Prog. Neurobiol. 52:1997;295-302.
63. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to k opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. USA. 90:1993;5162-5166.
64. Kubes P., Granger D.N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262:1992;H611-H615.
65. Kubes P., Suzuki M.M., Granger D.N. Nitric oxide an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:1991;4651-4655.
66. Kubes P., Kanwar S, Niu X.F., et al. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J. 7:1993;1293-1299.
67. Kubes P., Kurose I., Granger D.N. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267:1994;H931-H937.
68. Kupatt C., Weber C., Wolf D.A., Becker B.F., Smith T.W., Kelly R.A. Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: role of NFkappaB. J. Mol. Cell. Cardiol. 29:1997;2599-2609.
69. Kuriyama K., Ohkuma S. Role of nitric oxide in central synaptic transmission: effects on neurotransmitter release. Jpn. J. Pharmacol. 69:1995;1-8.
70. Kurose I., Kubes P., Wolf R. Inhibition of nitric oxide production: Mechanisms of vascular albumin leakage. Circ. Res. 73:1993;164-171.
71. Kurose I., Wolf R., Granger D.N. Dimethyl-L-arginine, an endogenous inhibitor of nitric oxide (NO) synthesis, elicits an inflammatory response in the rat mesenteric microcirculation. Gastroenterology. 106:1994;A245.
72. 9-tetrahydrocannabinol (THC), on the synthesis of tumor necrosis factor by human large granular lymphocytes. Cell. Immunol. 154:1994;99-108.
73. Ledebur H.C., Parks T.P. Transcriptional regulation of the intercellular adhesion molecule-1gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J. Biol. Chem. 270:1995;933-943.
74. Lee G., DeMaria A., Amstredam E.A., Realy-Vasquez E., Angel J., Morrison S., Mason D.T. Comparative effects of morphine, meperidine, and pentazocine and cardiocirculatory dynamics in patients with acute myocardial infarction. Am. J. Med. 60:1976;949-955.
75. Liu Y., Shenouda D., Bilfinger T.V., Stefano M.L., Magazine H.I., Stefano G.B. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res. 722:1996;125-131.
76. Luscinskas F.W., Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 8:1994;929-939.
77. Ma X.L., Lefer D.A.M., Zipkin R.E. S-nitroso-N-acetylpenicillamine is a potent inhibitor of neutrophil-endothelial interaction. Endothelium. 3:1993;32-39.
78. Mackay F., Loetscher H., Stueber D., Gehr G., Lesslauer W. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177:1993;1277-1286.
79. Magazine H.I. Detection of endothelial cell-derived nitric oxide: current trends and future directions. Adv. Neuroimmunol. 5:1995;479-485.
80. Magazine H.I., Liu Y., Bilfinger T.V., Fricchione G.L., Stefano G.B. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J. Immunol. 156:1996;4845-4850.
81. Magnusson U. In vitro effects of prepartum concentrations of oestradiol-17 beta on cell-mediated immunity and phagocytosis by porcine leukocytes. Veterinary Immunology & Immunopathology. 28:1991;117-126.
82. Majeed N.H., Przewlocka B., Machelska H., Przewlocki R. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacol. 33:1994;189.
83. Masana M.T., Heyes M.P., Mefford I.N. Indomethacin prevents increased catecholamine turn over in rat brain following systemic endotoxin challenge. Prog. Neuropsychopharmacol. Biol. Psychiatry. 14:1990;609-621.
84. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-kappa B DNA binding by nitric oxide. Nucleic Acids Res. 24:1996;2236-2242.
85. McCoy K.L., Gainey D., Cabral G.A. delta-9-tetrahydrocannabinol modulates antigen processing by macrophages. J. Pharmacol. Exp. Ther. 273:1995;1216-1223.
86. McEver R.P. Selections Current Opinion Immunology. 6:1994;75-84.
87. Mefford I.N., Masters C.F., Heyes M.P., Eskay R.L. Cytokine-induced activation of the neuroendocrine stress axis persists in endotoxin-tolerant mice. Brain Res. 557:1991;327-330.
88. Merrill J., Koyanagi Y., Chen I. Interleukin I and tumor necrosis factor alpha can be induced from mononuclear phagocytes by HIV-1 binding to CD4 receptor. J. Virol. 63:1989;4404-4408.
89. Miyagi M., Aoyama H., Morishita M., Iwamoto Y. Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes. Journal of Periodontology. 63:1992;28-32.
90. Mohanakumar K.P., Hanbauer I., Chiueh C.C. Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity. J. Chem. Neuroanatomy. 14:1998;195-205.
91. Mohankumar P.S., Thyagarajan S., Quadri S.K. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci. 48:1991;925-930.
92. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann. NY Acad. Sci. 811:1997;60-67.
93. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Eng. J. Med. 329:1993;2002-2012.
94. Moncada S., Palmer R.M., Higgs E.A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 12:1988;365-372.
95. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109.
96. Montague P.R., Gancayco C.D., Winn M.J., Marchase R.B., Friedlander M.J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 263:1994;973-977.
97. Montgomery K.F., Osborn L., Hession C., Tizard R., Goff D., Vassallo C., Tarr P.I., Bomsztyk K., Lobb R., Harlan J.M. Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA. 88:1991;6523-6527.
98. Nathan L., Chaudhuri G. Estrogens and atherosclerosis. Annual Review of Pharmacology & Toxicology. 37:1997;477-515.
99. Nitenberg A., Ledoux S., Attali J.R., Valensi P. Response of the coronary arteries to cold test and flow velocity increase is improved by deferoxamine but not by L-arginine in diabetic patients. Archives des Maladies du Coeur et des Vaisseaux. 90:1997;1037-1041. (French).
100. Niu X.F., Smith C.W., Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ. Res. 74:1995;1133-1140.
101. Noiri E., Hu Y., Bahou W.F., Keese C.R., Giaever I., Goligorsky M.S. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J. Biol. Chem. 272:1997;1747-1752.
102. Noiri E., Peresleni T., Srivastava N., Weber P., Bahou W.F., Peunova N., Goligorsky M.S. Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells. Am. J. Physiol. 270:1998;C794-C802.
103. Noiri E., Lee E., Testa J., Quigley J., Colflesh D., Keese C.R., Giaever I., Goligorsky M.S. Podokinesis in endothelial cell migration: role of nitric oxide. Am. J. Physiol. 274:1998;C236-C244.
104. Ohkuma S., Katsura M., Chen D.Z., Guo J.L., Kuriyama K. Hydroxyl radical scavengers enhance nitric oxide-evoked acetylcholine release from mouse cerebral cortical neurons. Mol. Brain Res. 34:1995;347-350.
105. Ohkuma S., Katsura M., Guo J.L., Narihara H., Hasegawa T., Kuriyama K. Role of peroxynitrite in [3H] gamma-aminobutyric acid release evoked by nitric oxide and its mechanism. Eur. J. Pharmacol. 301:1996;179-188.
106. Ohkuma S., Katsura M., Chen D.Z., Narihara H., Kuriyama K. Nitric oxide-evoked [3H] gamma-aminobutyric acid release is mediated by tow distinct release mechanisms. Brain Res. Mol. Brain Res. 36:1996;137-144.
107. Okada M., Suzuki A., Mizuno K., Asada Y., Ino Y., Kuwayama T., Tamakoshi K., Mizutani S., Tomoda Y. Effects of 17 beta-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitro. Cardiovascular Research. 34:1997;529-535.
108. Ottaviani E., Paemen L.R., Cadet P., Stefano G.B. Evidence for nitric oxide production and utilization as a bacteriocidal agent by invertebrate immunocytes. Eur. J. Pharmacol. 248:1993;319.
109. Paemen L.R., Porchet-Hennere E., Masson M., Leung M.K., Hughes T.K., Stefano G.B. Glial localization of interleukin-1a in invertebrate ganglia. Cell. Mol. Neurobiol. 12:1992;463-472.
110. Park S.K., Lin H.L., Murphy S. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappa B binding to DNA. Biochem. J. 322:1997;609-613.
111. Peng H.B., Libby P., Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270:1995;14214-14219.
112. Peunova N., Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Nature. 364:1993;453.
113. Peunova N., Enikolopov G. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature. 375:1995;68-73.
114. Pitei D.L., Watkins P.J., Edmonds M.E. NO-dependent smooth muscle vasodilatation is reduced in NIDDM patients with peripheral sensory neuropathy. Diabetic Medicine. 14:1997;284-290.
115. Pober J.S., Cotran R.S. Cytokines and endothelial cell biology. Physiol. Rev. 70:1990;427-451.
116. Prevot V., Rialas C., Croix D., Salzet M., Dupouy J-P., Puolain P., Beauvillain J.C., Stefano G.B. Morphine and anandamide coupling to nitric oxide stimulated GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res. 790:1998;236-244.
117. Prevot V., Croix D., Rialas C.M., Puolain P., Fricchione G.L., Stefano G.B., Beauvillain J.C. Estradiol coupling to endothelial nitric oxide production stimulates GnRH release from rat median eminence. Endocrinol. 140:1999;652-659.
118. Prevot, V., Croix, D., Bouret, S., Dutoit, S., Tramu, G., Stefano, G.B., Beauvillain, J.C., 1999b. Definitive evidence for the existence of plasticity in the external zone of the median eminence during the rat estrous cycle: implication of neuro-glio-endothelial interactions in the GnRH release. Neuroscience, in press.
119. Radomski M.W., Palmer R.M.J., Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 2:1987;1057-1058.
120. Radomski M.W., Palmer R.M.J., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the consitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA. 87:1990;10043-10047.
121. Ravichandran L.V., Johns R.A., Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Amer. J. Physiol. Heart Circ. Phy. 37:1995;H2216-H2223.
122. Read M.A., Whitley M.Z., Williams A.J., Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J. Exp. Med. 179:1994;503-512.
123. 3 opiate receptor subtype. Acta Pharmacol. Sin. 19:1998;403-407.
124. Roebuck K.A., Rahman A., Lakshminarayanan V., Janakidevi K., Malik A.B. H2O2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270:1995;18966-18974.
125. Salzet M., Stefano G.B. Invertebrate proenkephalin: delta opioid binding sites in leech ganglia and immunocytes. Brain Res. 768:1997;232.
126. Salzet M., Cocquerelle C., Verger-Bocquet M., Pryor S.C., Rialas C.M., Laurent V., Stefano G.B. Leech immunocytes contain proopiomelanocortin: nitric oxide mediates hemolymph POMC processing. J. Immunol. 159:1997;5400-5411.
127. Saville M.W., Taga K., Foli A., Broder S., Tosato G., Yarchoan R. Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood. 83:1994;3591-3599.
128. Scharrer B., Stefano G.B. Neuropeptides and autoregulatory immune processes. Scharrer B., Smith E.M., Stefano G.B. Neuropeptides and Immunoregulation. 1994;1-18 Springer-Verlag.
129. Sekkai D., Aillet F., Israel N., Lepoivre M. Inhibition of NF-kappaB and HIV-1 long terminal repeat transcriptional activation by inducible nitric oxide synthase 2 activity. J. Biol. Chem. 273:1998;3895-3900.
130. Service R.F. New role for estrogen in cancer? Science. 280:1998;987-988.
131. Shin W.S., Hong Y.H., Peng H.B., DeCaterina R., Libby P., Liao J.K. Nitric oxide attentuates vascular smooth muscle cell activation by interferon-gamma. The role of constitutive NF-kappa B activity. J. Biol. Chem. 71:1996;11317-11324.
132. Shivers S.C., Newton C., Friedman H., Klein T. delta-9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. Life Sci. 54:1994;1281-1289.
133. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-kappa B. Ann. Rev. Cell. Biol. 10:1994;405-455.
134. Simon D.I., Stamler J.S., Jaraki O., et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler. Thromb. 13:1993;791-799.
135. Sonetti D., Ottaviani E., Bianchi F., Rodriquez M., Stefano M.L., Scharrer B., Stefano G.B. Microglia in invertebrate ganglia. Proc. Natl. Acad. Sci. USA. 91:1994;9180-9184.
136. Sonetti D., Ottaviani E., Stefano G.B. Opiate signaling regulates microglia activities in the invertebrate nervous system. Gen. Pharmacol. 29:1997;39-47.
137. Specter S., Lancz G., Goodfellow D. Suppression of human macrophage function in vitro by delta-9-tetrahydrocannabinol. J. Leukocyte Biol. 50:1991;423-426.
138. 9-tetrahydrocannabinol and murine retrovirus. Friedman H., Specter S., Klein T.W. Advances in Experimental Medicine and Biology. 1991;135-141 Plenum Press, New York.
139. 9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacol. 13:1991;411-417.
140. Spiecker M., Peng H.B., Liao J.K. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of I kappa B alpha. J. Biol. Chem. 272:1997;30969-30974.
141. Spiecker M., Darius H., Kaboth K., Hubner F., Liao J.K. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukocyte Biol. 63:1998;732-739.
142. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell. 67:1994;301-314.
143. Squadrito F., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Arcoraci V., Minutoli L., Serrano M., Saitta A., Caputi A.P. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. European Journal of Pharmacology. 335:1997;185-192.
144. Stefano G.B. Role of opioid neuropeptides in immunoregulation. Prog. Neurobiol. 33:1989;149-159.
145. Stefano G.B. Invertebrate and vertebrate immune and nervous system signal molecule commonalities. Cell. Mol. Neurobiol. 12:1992;357-366.
146. Stefano G.B. Autoimmunovascular regulation: morphine and anandamide stimulated nitric oxide release. J. Neuroimmunol. 83:1998;70-76.
147. Stefano G.B. Substance abuse and HIV-gp120: are opiates protective? Arch. Immunologiae Therapiae Experimentalis. 47:1999;99-106.
148. Stefano G.B., Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv. Neuroimmunol. 4:1994;57-68.
149. Stefano G.B., Salzet M. Characterization and coupling of the leech CNS cannabinoid receptor to nitric oxide release. J. Biol. Chem. 753:1996;219-224.
150. Stefano G.B., Scharrer B. The presence of the m3 opiate receptor in invertebrate neural tissues. Comp. Biochem. Physiol. 113C:1996;369-373.
151. Stefano G.B., Salzet M. Invertebrate opioid precursors: evolutionary conservation and the significance of enzymatic processing. Int. Rev. Cytol. 187:1998;261-286.
152. Stefano G.B., Leung M.K., Zhao X., Scharrer B. Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes. Proc. Natl. Acad. Sci. USA. 86:1989;626-630.
153. Stefano G.B., Cadet P., Scharrer B. Stimulatory effects of opioid neuropeptides on locomotory activity and conformational changes in invertebrate and human immunocytes: evidence for a subtype of delta receptor. Proc. Natl. Acad. Sci. USA. 86:1989;6307-6311.
154. Stefano G.B., Melchiorri P., Negri L., Hughes T.K., Scharrer B. (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc. Natl. Acad. Sci. USA. 89:1992;9316-9320.
155. Stefano G.B., Bilfinger T.V., Fricchione G.L. The immune neuro-link and the macrophage: postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog. Neurobiol. 42:1994;475-488.
156. Stefano G.B., Hartman A., Bilfinger T.V., Magazine H.I., Liu Y., Casares F., Goligorsky M.S. Presence of the m3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270:1995;30290-30293.
157. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., Hartman A., Fricchione G.L., Liu Y., Makman M.H. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16:1996;109-144.
158. Stefano G.B., Liu Y., Goligorsky M.S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J. Biol. Chem. 271:1996;19238-19242.
159. Stefano G.B., Christensen V.B., Tonnesen E., Liu Y., Hughes T.K., Bilfinger T.V. Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence. J. Cardiovasc. Pharmacol. 30:1997;90-95.
160. Stefano G.B., Salzet B., Rialas C.M., Pope M., Kustka A., Neenan K., Pryor S.C., Salzet M. Morphine and anandamide stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res. 763:1997;63-68.
161. Stefano G.B., Salzet M., Magazine H.I., Bilfinger T.V. Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J. Cardiovasc. Pharmacol. 31:1998;813-820.
162. Stefano, G.B., Salzet, M., Bilfinger, T.V., 1998b. Chronic exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide. J. Cardiovasc. Pharmacol., in press.
163. Stefano G.B., Salzet M., Rialas C., Mattocks D.W., Fimiani C., Bilfinger T.V. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. Int. J. Cardiol. 64:1998;S3-S13.
164. 2 opioid receptor subtype on human vascular endothelium uncouples morphine stimulated nitric oxide release. Int. J. Cardiol. 64:1998;S43-S51.
165. Stefano G.B., Salzet B., Fricchione G.L. Enkelytin and opioid peptide association in invertebrates and vertebrates: immune activation and pain. Immunol. Today. 19:1998e;265-268.
166. Stefano, G.B., Prevot, V., Beauvillain, J.C., Bilfinger, T.V., Fimiani, C., Welters, I., Fricchione, G.L., 1999. Acute exposure of estrogen to human endothelia results in nitric oxide release mediated by an estrogen surface receptor coupled to intracellular calcium transients, in review.
167. Suematsu M., Tamatani T., Delano F.A., Miyasaka M., Forrest M., Suzuki H., Schmid-Schonbein G.W. Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression. Am. J. Physiol. 266:1994;H2410-H2415.
168. Suenaga R., Mitamura K., Evans M.J., Abdou N.I. Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus. Lupus. 5:1996;227-231.
169. Suenaga R., Evans M.J., Mitamura K., Rider V., Abdou N.I. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells. Journal of Rheumatology. 25:1998;1305-1312.
170. Suzuki A., Mizuno K., Asada Y., Ino Y., Kuwayama T., Okada M., Mizutani S., Tomoda Y. Effects of 17beta-estradiol and progesterone on the adhesion of human monocytic THP-1 cells to human female endothelial cells exposed to minimally oxidized LDL. Gynecologic & Obstetric Investigation. 44:1997;47-52.
171. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull. 41:1996;131-141.
172. Tang J-L., Lancz G., Spector S., Bullock H. Marijuana and immunity:
173. Togashi H., Sasaki M., Frohman E., Taira E., Ratan R.R., Dawson T.M., Dawson V.L. Neuronal (type 1) nitric oxide synthase regulates nuclear factor kappa B activity and immunologic (type II) nitric oxide synthase expression. Proc. Natl. Acad. Sci. USA. 94:1997;2676-2680.
174. Tonnesen E., Brix-Christensen V., Bilfinger T.V., Sanchez R.G., Stefano G.B. Endogenous morphine levels increase following cardiac surgery: decreasing proinflammatory cytokine levels and immunocyte activity. J. Int. Cardiol. 62:1998;191-197.
175. Turner A., Leung M.K., Stefano G.B. Peptidases of significance in neuroimmunoregulation. Scharrer B., Smith E.M., Stefano G.B. Neuropeptides in Neuroimmunology. 1994;152-169 Springer-Verlag.
176. Vaupel B., Kimes A.S., London E.D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attentuators of opioid withdrawal. Psychopharmacol. 118:1995;361-368.
177. Vaupel D.B., Kimes A.S., London E.D. Nitric oxide synthase inhibitors - preclinical studies of potential use for the treatment of opioid withdrawal. Neuropsychopharmacol. 13:1995;315-322.
178. Vlahov D., Anthony J.C., Celentano D., Soloman L., Chowdhury N. Trends of HIV-1 risk reduction among initiates into intravenous drug use 1982-1987. Am. J. Drug Alcohol Abuse. 17:1991;39-48.
179. Vlahov D., Graham N., Hoover D., Flynn C., Bartlett J.G., Margolick J.B., Lyles C.M., Nelson K.E., Smith D., Holmberg S., Farzadegan H. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+cell count. JAMA. 279:1998;35-40.
180. Wada K., Itoh T., Nakagawa M., Misao R., Mori H., Tamaya T. Estrogen binding sites in peripheral blood monocytes and effects of danazol on their sites in vitro. General Pharmacology. 23:1992;693-700.
181. Weissman D., Poli G., Fauci A.S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. AIDS Hum. Retrovirol. 9:1995;442-449.
182. Welters, I., Fimiani, C., Bilfinger, T.V., Stefano, G.B., 1999. NF-kB and opiate processes. Medical Hypothesis, in press.
183. Wessendorf G., Scheibl P., Zerbe P.S. Effect of estrogens on the immune system with regard to bovine placental retention. DTW - Deutsche Tierarztliche Wochenschrift. 105:1998;32-34.
184. Wink D., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. USA. 90:1993;9813-9817.
185. Xie Q., Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukocyte Biol. 56:1994;576-582.
186. Xu J.Y., Tseng L.F. Nitric oxide cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine and beta-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 274:1995;8-16.
187. Yamada K., Hayashi T., Kuzuya M., Naito M., Asai K., Iguchi A. Physiological concentration of 17 beta-estradiol inhibits chemotaxis of human monocytes in response to monocyte chemotactic protein 1. Artery. 22:1996;24-35.
188. Zheng Z.M., Spector S., Friedman H. Inhibition by delta-9-tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int. J. Immunopharmacol. 14:1992;1445-1452.